Loading...

CV CAPSOVISION INC Company Mergers 8-K Filing

CPSV

CV

CAPSOVISION INC

(CV)

2026 8-K

Annual Financial Results

Funding Agreement Signed

Development Agreement Update

FDA Submission Update

Financial Results Released

FDA Application Update

Management Change

Management Changes

Management Change

Financial Results Update

Initial Public Offerings

External Links:

CapsoVision, Inc. entered a Securities Purchase Agreement on March 16, 2026, raising approximately $14 million by issuing 2,867,089 shares of common stock at $4.883 per share. Additionally, as of March 20, 2026, the company announced preliminary financial results for the year ended December 31, 2025, and is focused on developing its second-generation CapsoCam Colon capsule.

AI Assistant

CAPSOVISION INC

2026

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.